Federal government websites often end in. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. NCBI Bookshelf. Stephen W. Leslie ; Thushanth Sooriyamoorthy. Authors Stephen W. Leslie 1 ; Thushanth Sooriyamoorthy 2. Erectile dysfunction ED is a prevalent and multifaceted condition that predominantly afflicts males beyond 40 years, with its prevalence escalating globally. This condition is characterized by the consistent or recurrent inability to attain and maintain an erection sufficient for satisfactory sexual performance.
The etiology of ED is diverse, encompassing organic, psychogenic, and mixed factors, often interwoven with comorbidities such as diabetes, cardiovascular disease, and neurologic disorders. This complexity underscores the significance of discerning the root causes to guide appropriate management.
The psychological and emotional ramifications of ED can be profound, impacting not only the afflicted individuals but also their partners. Unaddressed, it may precipitate anxiety, depression, diminished self-esteem, and strained interpersonal relationships. Thus, the comprehensive evaluation and management of ED carry substantial importance.
Fortunately, a plethora of therapeutic modalities is at the clinician's disposal. These range from the administration of oral phosphodiesterase type 5 inhibitors, hormone replacement therapies, and external vacuum devices to the application of urethral suppositories, intracavernosal injections, topical gels, and sex therapy. This activity reviews the evaluation and treatment of ED and highlights the role of the interprofessional team in managing patients with this condition.
Objectives: Apply evidence-based treatments for erectile dysfunction, including oral phosphodiesterase type 5 inhibitors, hormone replacement therapies, and other therapeutic modalities as indicated.
